Wound care |

How universal patient assessment can help minimise post-surgical complications: the simplified Surgical Site Event Risk Assessment (SSERA) model

This article explores the clinical and economic value of a universal assessment for surgical patients across all major procedures. It then proposes a simplified risk assessment framework to identify those patients most likely to benefit from post-operative interventions such as the use of incisional negative pressure therapy.

A recent study¹ developed a universal risk assessment tool for all patients undergoing major surgery – the Surgical Site Event Risk Assessment (SSERA) model. A simplified version of this model offers a practical and pragmatic way to identify high-risk patients who might otherwise be overlooked, with the aim of reducing the occurrence of surgical site complications.

What are the aims of the simplified surgical assessment tool?


The key aims are to¹:

  • Identify common risk factors that can be used by a range of healthcare professionals to screen patients across all surgical procedures
  • Provide an objective foundation for decision-making that may have a positive influence on reducing surgical site complications (SSC) such as surgical site infection 

How can a surgical risk assessment help reduce SSIs cost-effectively?

A standardised universal surgical assessment framework, such as the simplified SSERA assessment model, is designed to be straightforward and practical to implement. It allows clinicians to balance clinical benefit with economic impact when considering risk reduction initiatives, such as the use of NPWT for incision care, for example.

Using a simplified risk assessment framework to identify those high-risk patients with the greatest potential to benefit from such an intervention is likely to be clinically appropriate and cost-effective in the long term¹.

What is the impact of SSIs?

 
‘Surgical wound infections’ or ‘surgical site infections’?
Throughout this article, we use the term ‘surgical site’ rather than ‘surgical wound’ complications or infections. This is because our discussion also covers complications and infections that may occur outside the wound itself, in the skin of the peri-wound area, for example.

A recent study has estimated that, worldwide, 11 out of 100 general surgical patients are likely to develop an infection within 30 days of surgery². The severity, duration and outcome of infections are highly variable, but the impact on those patients affected and on the global health economy is huge.

What are the key risk factors for surgical patients?

The risk factors most frequently identified, evidenced and cited were¹:

  • obesity
  • diabetes
  • American Society of Anesthesiologists (ASA) score
  • female gender
  • tobacco use
  • age
  • chronic obstructive pulmonary disease (COPD)
  • procedure duration
  • wound classification
  • surgical urgency 

The simplified SSERA framework includes six of these factors (shown in bold), chosen to provide the most relevant guidance in post-operative incision care.

Intrinsic risk factors for surgical patients

  • Obesity (BMI ≥ 30)
    • BMI ≥30–34.9 (Class I)
    • BMI ≥35–39.9 (Class II)
    • BMI ≥40 (Class III)³
  • Diabetes: The International Diabetes Federation estimated that 10.5% of the global adult population had diabetes in 2021, and the condition is projected to affect 643 million people by 2030⁴. The relationship between diabetes and increased risk for SSI is widely recognised⁵.
  • ASA (American Society of Anesthesiologists) Physical Status Classification System (score ≥ III): This system is designed to assess and communicate a patient’s pre-anaesthesia medical comorbidities⁶. It does not predict risk as a standalone model, but it includes many independent risk factor predictors. There are six classes:
    • I (a normal healthy patient)
    • II (patient with mild systemic disease)
    • III (patient with severe systemic disease)
    • IV (patient with severe systemic disease that is a constant threat to life)
    • V (moribund patient who is not expected to survive without the operation)
    • VI (declared brain-dead patient whose organs are being removed for donor purposes)

No one of these factors alone confers ‘high risk’ status, but in combination with other factors they increase or compound risk.

Extrinsic risk factors for surgical patients

  • Wound classification (II–IV): The Association of Perioperative Registered Nurses (AORN) incision classification system⁷ considers surgical site infection risk:
    • I (clean) – infection risk ≤2%
    • II (clean-contaminated) – infection risk 4%–10%
    • III (contaminated) – infection risk >10%
    • IV (dirty or infected) – infection risk >25%. Classes III and IV automatically confer ‘high risk’ status; class II may do so in combination with other risk factors.
  • Procedure classification (urgent/emergency): Emergency surgery always  confers ‘high risk’ status; urgent surgery may do so in combination with other risk factors.
  • Procedure duration (>120 mins or >75th percentile): Long duration is too simple a metric to assess risk. The model includes as risk factors all procedures over 120 minutes duration and shorter procedures that exceed the 75th percentile for the given procedure.

The advantages of the simplified SSERA risk assessment model

The model helps clinicians reduce the incidence of preventable surgical site complications by:

  • Assisting pragmatic decision-making around the use of interventions such as closed negative pressure therapy
  • Allowing a range of healthcare professionals to contribute to the assessment and gain an understanding of the patient’s risks and mitigation strategies
  • Helping healthcare professionals raise awareness among patients of general risk mitigation activities, such as smoking cessation

Post-operative risk assessment and product choice

Product indications for post-operative incision site care 

A ‘low’ or ‘moderate’ assessed risk indicates an advanced wound dressings such as Mepilex Border Post-Op.

A ‘high risk’ indicates the use of a closed incision negative pressure system (ci)NPT system, such as Avance Solo

Where the assessed risk is ‘elevated’, Avance Solo may also be suitable to reduce the likelihood of surgical site complications (SSC). This will depend on the perceived cost benefit in each case. 

Avance Solo is a single-use system NPWT system for closed surgical incisions. It is designed to:

•    reduce surgical site complications
•    promote healing
•    facilitate patient mobility

It is indicated for use after orthopaedic, cardiothoracic, OBGYN and general/colorectal.

Select country

Get knowledge, learn about our products, get support and more.

Malaysia
Select market
Go to United States

Find jobs, our financial reports and more.

Mölnlycke corporate

Are you a healthcare professional?

This webpage contains information that is only intended for healthcare professionals. By selecting ‘Yes, I am’ you confirm that you are a healthcare professional.

No, I am not a healthcare professional